PRİMER VAJİNAL KANSERDE VAJİNAL SU-BAZLI JEL YARDIMLI MANYETİK REZONANS GÖRÜNTÜLEME

Öz

İki vajinal squamoz hücreli karsinom olgusunun, vajene su-bazlı jel doldurularak alınan manyetik rezonans görüntülemelerinin, genel anestezi altında yapılan fizik muayene bulgularına yapabileceği ek katkıları değerlendirdik. Sunduğumuz iki olgu da genel anestezi altında yapılan fizik muayeneye göre evre 1 olarak değerlendirildi. Ardından her iki hastaya da vajene su-bazlı jel ile doldurup vajen duvarlarının kollapsını engelleyen, bu sayede vajendeki tümör anatomisini ve yayılımını daha iyi gösteren bir teknikle manyetik rezonans görüntüleme(MRG) yapıldı. Olgulardan birinin MRG bulgularında subvajinal dokulara infiltrasyon izlendi. Bu nedenle bu hastada cerrahi tedaviden vazgeçtik ve primer kemoradyasyon ile tedaviye karar verdik. Vajinal su-bazlı jel ile yapılan pelvik MRG’nin vajinal kanser olgularında tümör anatomisini ve paravajinal dokulara infiltrasyonu göstermede genel anestezi altında yapılan fizik muayeneye üstün olduğuna ve bu nadir jinelkolojik kanserlerin daha ideal yönetimine katkı sağlayacağına inanmaktayız.  

Anahtar Kelimeler

• Vajinal kanser,Manyetik rezonans görüntüleme,Su-bazlı jel

MAGNETIC RESONANCE IMAGING GUIDES THE MANAGEMENT OF PRIMARY VAGINAL CANCER

Öz

We report two cases of vaginal squamoz cell carcinoma with magnetic resonance imaging findings. Both of the patients were staged as stage 1 with physical examination findings under general anesthesia. We performed magnetic resonance imaging for these patients filling water-based gel to their vagina during the scan for preventing collapse of vaginal walls so that we could reveal the tumor anatomy and extension more accurately. One of the patients MRI findings showed an infiltration through subvaginal tissues. So we abandoned surgical treatment for this patient and choose radiotherapy. We think that, pelvic MRI performed with vaginal water-based gel can demonstrate tumor infiltration to paravaginal tissues better than physical examination, which helps well-directed management of this rare gynecological cancer

Anahtar Kelimeler

• Vaginal cancer,Magnetic resonance imaging,Water-based gel

Kaynakça

1. 1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9
2. 2. Daling JR, Madeleine MM, Schwartz SM, et al. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002;84:263e70.
3. 3. Frank SJ, Deavers MT, Jhingran A, Bodurka DC, Eifel PJ. Primary adenocarcinoma of the vagina not associated with diethylstilbestrol (DES) exposure. Gynecol Oncol 2007;105:470
4. 4. Lilic V, Lilic G, Filipovic S, Visnjic M, Zivadinovic R. Primary carcinoma of the vagina. J BUON 2010;15:241–7.
5. 5. Hacker NF, Eifel PJ, van der Velden J. Cancer of the vagina. Int J Gynaecol Obstet 2012;119(Suppl. 2):S97–9.
6. 6. Miner TJ, Delgado R, Zeisler J, et al. Primary vaginal melanoma: a critical analysis of therapy. Ann Surg Oncol 2004;11:34–9.
7. 7. Kirschner AN, Kidd EA, Dewees T, Perkins SM. Treatment approach and outcomes of vaginal melanoma. Int J Gynecol Cancer 2013;23:1484–9.
8. 8. Beller U, Benedet JL, Creasman WT, et al. Carcinoma of the vagina. FIGO 26th annual report on the results of treatment in gynecological cancer. Int J Gynaecol Obstet 2006;95(Suppl. 1):S29–42. 9. Hacker NF, Eifel PJ, van der Velden J. Cancer of the vagina. Int J Gynecol Obstet 2012;119(Suppl. 2):S97e9

9. 10. Madsen BS, Jensen HL, van den Brule AJ, et al. Risk factors for invasive squamous cell carcinoma of the vulva and vaginaepopulation-based case-control study in Denmark. Int J Cancer 2008;122:2827e34.
10. 11. Liao JB, Jean S, Wilkinson-Ryan I, et al. Vaginal intraepithelial neoplasia (VAIN) aft er radiation therapy for gynecologic malignancies: a clinically recalcitrant entity. Gynecol Oncol 2011;120(1):108e12.
11. 12. Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynaecol Obstet 2009;105(1):3e4.
12. 13. Rajaram S, Maheshwari A, Srivastava A Staging for vaginal cancer Best Practice & Research Clinical Obstetrics and Gynaecology 29 (2015) 822e832
13. 14. Bipat S, Glas AS, van der Velden J, et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 2003;91(1):59e66.
14. 15. Hricak H, Gatsonis C, Chi DS, et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American
15. 16. Taylor MB, Dugar N, Davidson SE, et al. Magnetic resonance imaging of primary vaginal carcinoma. Clin Radiol 2007; 62(6):549e55.
16. 17. Lee LJ, Jhingran A, Kidd E, et al. ACR appropriateness criteria® management of vaginal cancer. Oncology 2013 [accessed 28.10.14], http://www.cancernetwork. com/oncology-journal/acr-appropriateness-criteriamanagement-vaginal-cancer/accessed.
17. 18. Griffi n N, Grant LA, Sala E. Magnetic resonance imaging of vaginal and vulval pathology. Eur Radiol 2008;18:1269e80
18. 19. Chang YC, Hricak H, Th urnher S. Lacey CG vagina: evaluation with MR imaging. Part II. Neoplasms. Radiology 1988;169: 175e9.
19. 20. Young P, Daniel B, Sommer G, Kim B, Herfk ens R Intravaginal Gel for Staging of Female Pelvic Cancers Preliminary Report of Safety, Distention, and Gel-Mucosal Contrast During Magnetic Resonance Examination. Comput Assist Tomogr & Volume 36, Number 2, March/ April 2012
20. 21. Atcı N, Özgür T, Öztürk F, Dolapçıoğlu KS Utility of intravaginal ultrasound gel for local staging of cervical carcinoma on MRI. Clinical Imaging 40 (2016) 1104- 1107